Eculizumab: Phase II data

An open-label, international Phase II trial in 102 living-donor kidney transplant recipients at risk

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE